GAO re­port tracks the growth of an $89B drug R&D sec­tor as bio­phar­ma sales soared

Just how much does phar­ma re­al­ly pay for drug re­search and de­vel­op­ment, how does that ac­tu­al­ly stack up as a per­cent­age of sales and who …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.